# Sang Joon Shin

Source: https://onco.cc/people/shin-sang-joon/  
OnCo record `shin-sang-joon` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Sang Joon Shin is a Yonsei medical oncologist active in colorectal cancer and melanoma immunotherapy trials.

## Summary

Sang Joon Shin is Professor of Medical Oncology at Severance Hospital, Yonsei University, in Seoul, specialising in colorectal cancer and melanoma. He leads colorectal and melanoma research at Yonsei Cancer Center and is active in immunotherapy trials in both diseases. He has held investigator roles in studies of KRAS G12C inhibitors, anti-EGFR antibodies and checkpoint inhibitors, bringing Korean patients into these programmes. His interests are colorectal cancer, melanoma, immunotherapy and clinical trials.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Professor of Medical Oncology; colorectal cancer and melanoma
- Specialisms: Colorectal cancer; Melanoma; Immunotherapy; Clinical trials

## Sources

- Yonsei Cancer Center: https://sev.severance.healthcare
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Shin%20SJ%5BAuthor%5D%20Yonsei%20colorectal%20melanoma

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Melanoma](https://onco.cc/cancers/melanoma/)
- targets: [KRAS](https://onco.cc/targets/kras/)
- institutions: [Severance Hospital, Yonsei University](https://onco.cc/institutions/severance/)
- key papers: [EV-302: enfortumab vedotin plus pembrolizumab replaces chemotherapy as first treatment for advanced bladder cancer](https://onco.cc/key-papers/paper-ev-302-nejm-2024/)

---
JSON: https://onco.cc/api/v1/entities/shin-sang-joon.json